New Genetic Test Could Diagnose Brain Tumours in 2 Hours
Researchers at the University of Nottingham have developed a new genetic test that can diagnose brain tumours in…
Ubrogepant Eases Prodromal Migraine Symptoms
The clinical utility of the calcitonin gene–related peptide (CGRP) receptor antagonist ubrogepant may extend beyond the treatment of…
FDA Authorizes First Digital Therapeutic for Migraine
The US Food and Drug Administration (FDA) has granted marketing authorization to CT-132 (Click Therapeutics), an adjunctive, first-in-class…
Quantum Computing and Drug Development
Dear reader, in recent years we have witnessed a rapid rise in quantum computing, a technology that represents…